AKASA vs Commure (2026)

AI Health Index verifiedSeptember 25, 2026
Verdict

Two vendors selling AI across the revenue cycle, assembled differently. AKASA sells hospitals and health systems prebill coding and documentation review and agents that check authorization and claim status on payer portals, with its own revenue cycle experts working in the loop. Commure assembled its platform by acquisition, rolling up Athelas, Augmedix and Memora Health, so that ambient documentation flows into autonomous coding, documentation integrity and claims inside one company. Its documentation runs from AI drafted notes to synchronous human scribes. A health system that wants coding and documentation review on top of how it documents today looks at AKASA. One that wants documentation and the revenue cycle from one company, scribe included, looks at Commure.

The case for AKASA
  • Prebill coding and documentation review, plus status agents on payer portals, without changing how notes are written.
  • Models fine tuned for each health system, with AKASA's own revenue cycle experts working in the loop.
  • Named deployments at Cleveland Clinic, Montage Health and Methodist Health System.
The case for Commure
  • Documentation that feeds coding and claims inside one company, from the Augmedix ambient suite through Athelas revenue cycle management.
  • A spectrum of service levels: AI drafted notes, AI with specialist review, and synchronous human documentation.
  • Reach across more than 50 record systems including Epic, Oracle Health and MEDITECH, and a Vizient contract giving member health systems negotiated access to the Augmedix suite.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Commure are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact AKASA Commure
Primary category RCM & Prior Auth AI Ambient Scribes
Founded Not recorded 2017
Headquarters South San Francisco, California Mountain View, California
Website akasa.com commure.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
A
AKASA
C
Commure
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Change Log

Product updates

The latest logged changes from each vendor, newest first, each linked to its source.

AKASA

  • Product / capability

    AKASA launched an autonomous platform for inpatient medical coding and clinical documentation integrity, building on its AI prebill review products.

    Source
All 1 AKASA update →

Commure

  • Product / capability

    Commure Pro, the former PatientKeeper, added an AI Incidental Findings dashboard in its 27 October cloud release that lists patients with incidental findings needing follow up after discharge; Commure switches it on by request.

    Source
  • EHR / interoperability

    Commure Autonomous Coding received Epic Toolbox designation in the Fully Autonomous Coding category on Epic Showroom, adding to the designation Commure Ambient AI already holds for ambient voice recognition.

    Source
  • Product / capability

    Commure released version 2026.3.1 of its Pro iOS app.

    Source
All 3 Commure updates →
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.

AKASA

AKASA, formerly Alpha Health, sells generative AI for the provider side of the revenue cycle to hospitals and health systems. Its listed solutions are the Prebill Optimization Suite, which combines Coding Optimizer (missed coding opportunities, quality and compliance risks) and CDI Optimizer (documentation gaps for clinical documentation integrity teams); AI Advisor, a research assistant for revenue cycle staff; Auth Status, which checks pending prior authorization requests on payer portals and records the results; and Claim Status, which does the same for outstanding claims.

Source: AI Health Index, September 2026

Commure

Commure sells ambient clinical documentation that feeds autonomous coding, clinical documentation integrity and claims automation, as part of a General Catalyst backed group built from Athelas, Augmedix and Memora Health. Commure Ambient AI comes in three service levels: Ambient AI on its own, Ambient Assist with specialist review of the AI draft, and Ambient Live with real time human documentation support, a ladder that carries forward the Augmedix Go, Assist and Live suite.

Source: AI Health Index, September 2026

FAQ

Questions buyers ask

How do AKASA and Commure work with the EHR?

AKASA's Montage Health case studies describe claim and authorization status automation working alongside Epic, returning detailed status information into the record to drive follow-up, and reducing an Epic authorization work queue by 22 percent.

Commure Ambient AI holds Epic Toolbox designation for Ambient Voice, announced April 30, 2025: notes captured in the Haiku mobile app flow into Hyperdrive for the clinician's final review and editing. North East Medical Services runs the product fully integrated with Epic, and the product page describes syncing patient data and documentation directly with the EHR. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.

How are AKASA and Commure priced and sold?

AKASA sells to hospitals and health systems by solution, each with its own demo request. The platform page describes a dedicated account manager, production reporting, and the option of AKASA's own revenue cycle experts taking over workflows rather than staff using the tools, a service component that will shape the cost.

Commure Scribe's pricing page offers ScribeCore free for seven days with no card required, ScribePro at $708 a year billed annually, shown against a list price of $1,068, and ScribeEnterprise on a custom quote with templates built for the practice and notes synced to the EHR; the page description gives plans from $59 a month. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.

How do AKASA and Commure handle patient data?

With AKASA, the data is complete clinical and financial documentation for whole health systems. Safety engineering, meaning guardrails, hallucination mitigation and how a safety event is handled, is not described.

Under the General Terms of Agreement the customer owns its Customer Data, a term defined to exclude PHI, and Commure makes stored Customer Data available on written request after termination. The same terms let Commure create deidentified data, own it outright, use and disclose it for any purpose the law does not prohibit, and aggregate it with other customers' deidentified data to produce insights. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.

Which settings and specialties do AKASA and Commure cover?

AKASA sells to hospitals and health systems, states a client base of 500 hospitals across all 50 states, and covers coding and documentation integrity before billing, prior authorization status, claim status and a research assistant for revenue cycle staff.

Commure says its models, prompts and formats adapt to each specialty. The AI only tier is aimed at ambulatory and lower acuity settings, with the staffed tiers covering more complex work, and Augmedix markets a dedicated emergency medicine app and AI tuned for oncology. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers.

Disclosure

Both records were reviewed on this site in September 2026. Both put people behind the software: AKASA its revenue cycle experts, Commure its specialist reviewers and human scribes.

Both sell a return measured by the party being paid for it, so ask each for its ratio of codes removed to codes added. Commure publishes its legal, security and billing documents on the athelas.com legal index rather than commure.com, so look there before concluding a document does not exist. AKASA publishes no price.